Hepatic consequences of vascular adhesion protein-1 expression

J Neural Transm (Vienna). 2011 Jul;118(7):1055-64. doi: 10.1007/s00702-011-0647-0. Epub 2011 Apr 22.

Abstract

The liver is constantly exposed to antigens present in the blood and to particulate antigens delivered from the gut. To maintain effective levels of immune surveillance and yet tolerate food antigens, the hepatic environment has become highly specialised. A low flow environment exists within the hepatic sinusoids that not only facilitates the exchange of toxins and nutrients within the liver parenchyma, but also provides an ideal niche for the recruitment of leukocytes. One such adhesion molecule involved in this process, the vascular adhesion protein-1 (VAP-1), is unusual in the context of the leukocyte adhesion cascade in that it is both an adhesion molecule and a primary amine oxidase. In this review, we examine the biological functions of VAP-1 and examine what role this molecule might play in the establishment and progression of chronic liver disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amine Oxidase (Copper-Containing) / physiology*
  • Animals
  • Cell Adhesion Molecules / physiology*
  • Chemotaxis, Leukocyte / physiology*
  • Chronic Disease
  • Cross-Linking Reagents / pharmacology
  • Disease Progression
  • Hepatocytes / enzymology*
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Humans
  • Liver / enzymology*
  • Liver / metabolism
  • Liver / pathology
  • Liver Diseases / enzymology*
  • Liver Diseases / pathology
  • Mice

Substances

  • Cell Adhesion Molecules
  • Cross-Linking Reagents
  • AOC3 protein, human
  • Amine Oxidase (Copper-Containing)
  • semicarbazide-sensitive amine oxidase-vascular adhesion protein-1, mouse